Urea channel inhibitors: A new functional class of aquaretics

Kidney International

Volumn 83, Issue 6, 2013, Pages 991-993

  Knepper, Mark A ^a   Miranda, Carlos A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; NITROGEN; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UREA; UREA CHANNEL INHIBITOR; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

CHANNEL GATING; DIURESIS; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; DRUG SELECTIVITY; ELECTROLYTE EXCRETION; HUMAN; HYPONATREMIA; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; KIDNEY MEDULLA; NITROGEN BALANCE; NITROGEN URINE LEVEL; NONHUMAN; OSMOTIC DIURESIS; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; UREA CYCLE;

EID: 84882264099     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.94     Document Type: Note

References (10)

1. Li F, Lei T, Zhu J et al. A novel small-molecule thienoquinolin urea transporter inhibitor acts as a potential diuretic. Kidney Int 2013; 83: 1076-1086.
2. Yao C, Anderson MO, Zhang J et al. Triazolothienopyrimidine inhibitors of urea transporter UT-B reduce urine concentration. J Am Soc Nephrol 2012; 23: 1210-1220.
3. Anderson MO, Zhang J, Liu Y et al. Nanomolar potency and metabolically stable inhibitors of kidney urea transporter UT-B. J Med Chem 2012; 55: 5942-5950.
4. Levin EJ, Cao Y, Enkavi G et al. Structure and permeation mechanism of a mammalian urea transporter. Proc Natl Acad Sci USA 2012; 109: 11194-11199.
5. Kokko JP, Rector FC Jr. Countercurrent multiplication system without active transport in inner medulla. Kidney Int 1972; 2: 214-223.
6. Fenton RA, Chou CL, Stewart GS et al. Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct. Proc Natl Acad Sci USA 2004; 101: 7469-7474.
7. Berliner RW, Levinsky NG, Davidson DG et al. Dilution and concentration of the urine and the action of antidiuretic hormone. Am J Med 1958; 27: 730-744.
8. Tomita K, Pisano JJ, Knepper MA. Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest 1985; 76: 132-136.
9. Ecelbarger CA, Kim GH, Terris J et al. Vasopressin-mediated regulation of ENaC abundance in rat kidney. Am J Physiol Renal Physiol 2000; 279: F46-F53.
10. Torres VE, Chapman AB, Devuyst O et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; 367: 2407-2418.